Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More
Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Monday that Aphria RX GmbH has received a trading license in Germany.
What Happened
The new permit will allow the Canadian cannabis giant to sell and distribute a broad range of medical marijuana products to pharmacies, hospitals, and medical wholesalers throughout Germany.
The news comes shortly after Aphria RX GmbH obtained the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act.
That license allowed the company to cultivate and manufacture a broad commercial range of medical cannabis, providing patients with better access to high-quality medical cannabis produced in Germany.
Read Also: Tilray Gets Second Approval …